© 2020 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.
July 02, 2020
Authors of JAMA Oncology opinion piece see priorities set in response to the pandemic as a chance to discourage low-value cancer care.
June 30, 2020
"I don't know about you, but in March I was scared; now I'm mostly depressed..."
June 29, 2020
Any rollback needs to be based on evidence, say authors
Company's price is lower than ICER's $50k per-QALY assessment.